Compare AORT & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | ASH |
|---|---|---|
| Founded | 1984 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1993 | N/A |
| Metric | AORT | ASH |
|---|---|---|
| Price | $45.71 | $61.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $49.36 | ★ $60.14 |
| AVG Volume (30 Days) | 355.3K | ★ 994.9K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $422,646,000.00 | ★ $1,824,000,000.00 |
| Revenue This Year | $15.97 | $3.29 |
| Revenue Next Year | $10.96 | $3.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.81 | N/A |
| 52 Week Low | $21.97 | $45.21 |
| 52 Week High | $48.04 | $77.29 |
| Indicator | AORT | ASH |
|---|---|---|
| Relative Strength Index (RSI) | 54.33 | 75.31 |
| Support Level | $42.68 | $57.22 |
| Resistance Level | $46.02 | $59.40 |
| Average True Range (ATR) | 1.37 | 1.78 |
| MACD | -0.22 | 0.68 |
| Stochastic Oscillator | 66.31 | 99.85 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.